AI-enabled phenotypic analysis

Alvus Health enables patient-derived epithelial organoids for high-throughput, multi-modal genetics-proteomics-histology phenotypic profiling for biopharmaceutical discovery. The company maintains a surrogate organ biobank covering intestinal, lung, stomach, cerebral, urinary, and ovarian tissues, and in March 2024 partnered with NASA, MGH, and SpaceTango to send organoids to space.

Read more

cell transfection for gene editinghigh-throughput automated organoid culturinghigh throughput screeningmultiplex imagingorganoid culturingsequencing